All News

A Letter to My Support System

August 7th 2025, 5:00pm

Article

I survived peritoneal mesothelioma thanks to the love, prayers, and support of family, friends, and strangers who reminded me I was never alone.

Zusduri Shows Durable Response in Non–Muscle-Invasive Bladder Cancer

August 7th 2025, 4:00pm

Article

In a phase 3 trial, 72.2% of patients with recurrent low-grade bladder cancer kept complete response at 24 months after Zusduri treatment.

AI May Better Predict Cancer Biomarkers and Patient Survival

August 7th 2025, 3:00pm

Article

An artificial intelligence-based image analysis model has more accurately predicted cancer biomarkers and outcomes compared with conventional methods.

The Importance of Expert Opinions After a GIST Diagnosis

August 7th 2025, 1:00pm

Video

Getting an expert opinion is essential after a rare cancer diagnosis like GIST, as each patient’s situation is unique, according to Dr. Weijing Sun.

Survivor Builds Support Network for Women With Cancer

August 6th 2025, 9:00pm

Article

Staci Kirk, a six-time cancer survivor, founded the Stiletto Boss Foundation to empower women through mentorship, self-advocacy and healing.

Finishing Chemo with Stage 4 Lung Cancer: Facing Hope and Uncertainty

August 6th 2025, 8:00pm

Video

In an interview with CURE, Clara Cirks shares the emotional weight of finishing chemo while facing ongoing immunotherapy and the uncertainty it brings.

FDA Approves Modeyso for Patients with Diffuse Midline Glioma

August 6th 2025, 6:55pm

Article

The U.S. FDA granted accelerated approval to Modeyso for patients with diffuse midline glioma with an H3 K27M mutation with progressive disease.

Expert Oncologist Breaks Down Newest FDA Approval in Lung Cancer

August 6th 2025, 5:00pm

Article

Following the June 2025 FDA approval of Datroway, Dr. Jacob A. Sands explained the significance of the regulatory approval for patients with lung cancer.

Shaved Heads and Shared Tears: How My Sister Helped Me Face Cancer

August 6th 2025, 4:00pm

Article

During my breast cancer journey, my sister Kelly’s love and support — especially the day she shaved my head — gave me strength, comfort, and control.

FDA Accepts Breyanzi sBLA for Relapsed Marginal Zone Lymphoma

August 6th 2025, 2:55pm

Article

The FDA accepted a supplemental application for Breyanzi to treat adults with relapsed or refractory marginal zone lymphoma after two prior therapies.